1. Incidence of VTE amongst patients undergoing curative resection for colorectal cancer – an underestimated clinical entity. Issue 164 (April 2018) Authors: Rees, P.A.; Clouston, H.W.; Shaker, H.; Castle, J.; Duff, S.; Kirwan, C.C. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patient, tumour and operative factors influencing perioperative hypercoagulability in colorectal cancer. Issue 164 (April 2018) Authors: Rees, P.A.; Clouston, H.W.; Shaker, H.; Castle, J.; Duff, S.; Kirwan, C.C. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-32 - Patient, tumour and operative factors influencing perioperative hypercoagulability in colorectal cancer. Issue 140 (April 2016) Authors: Clouston, H.W.; Rees, P.A.; Shaker, H.; Duff, S.; Kirwan, C.C. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pre-operative systemic coagulation factors as biomarkers in colorectal cancer. Issue 164 (April 2018) Authors: Rees, P.A.; Clouston, H.W.; Shaker, H.; Castle, J.; Duff, S.; Kirwan, C.C. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The effects of exogenous coagulation factors, and their inhibitors, on in vitro proliferation and migration in colorectal cancer. Issue 164 (April 2018) Authors: Rees, P.A.; Clouston, H.W.; Lamb, R.; Duff, S.; Kirwan, C.C. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗